GRM5 and Alzheimer disease: Thus, glutamate activation of mGlu5 can lead to multiple signalling mechanisms and signal transduction pathways, suggesting that any possible alteration in its subcellular localisation could alter glutamate signalling in the APP/PS1 model of AD in different ways.